News About: Pharm. Industry
CJ Corp Announces Direct Management of Pharmaceutical Business Unit
CJ Corporation announced on April 11th that its pharmaceuticals business unit, CJ Pharmaceutical Division, is now under the direct management by President Kim Ju-hyung of CJ Corp., reflective of the company's strategi...
AstraZeneca Korea Disputes Results from Latest Asthma Study
AstraZeneca Korea said the results from the CONCEPT (CONtrol CEntered Patient Treatment) study, which claimed the stable-dose Seretide (salmeterol/fluticasone propionate combination) is more effective over the adjusta...
Sanofi-Synthelabo Korea Reports Financial Performance Results
Sanofi-Synthelabo Korea (currently Sanofi-Aventis after the merge between Sanofi-Synthelabo and Aventis) reported the financial performance results from last year, in which the company recorded the sales of 162.0 bill...
Domestic Firms Eye on Original Drug Patent Expirations
The domestic pharmaceutical firms are strategically observing on the current and upcoming patent expirations of the blockbuster drugs, with their annual sales surpassing over $1 billion USD on an individual brand basi...
Chairman and CEO of Novartis AG Makes Visit to Nation
Chairman and Chief Executive Officer Daniel Vasella of Novartis AG recently made a visit to the nation for the first time, where he had an opportunity to make close observations on the business growth prospects for th...
Il-yang Makes Licensing Agreement for Grupo Uriach's Rupafin
Il-yang Pharmaceutical Co. announced last week that the company signed an exclusive domestic licensing agreement for Rupafin (rupatadine fumarate), a novel antihistamine agent for the management of diseases with aller...
KFDA Approves Phase III Clinical Trial for Aropotin
TS Corporation announced on April 6th that the Korea Food and Drug Administration (KFDA) has approved the phase III clinical trial for Aropotin, an independently developed, bioengineered treatment for the anemia assoc...
Astellas Pharma Korea Officially Launched
The merger between two Japanese pharmaceutical organizations, Yamanouchi Pharmaceutical Co. Ltd and Fujisawa Pharmaceutical Co. Ltd, has formed the new commercial entity under the name Astellas Pharma Korea, Inc. in t...
Large-Scale Firms Continue Gain Bigger Market Shares
The compilation report on the total revenues generated by the pharmaceutical companies last year indicates that there is an increasing level of performance gap between the large and small sized firms, indicated by a h...
KFDA Approves Atacand for Treatment of Heart Failure
AstraZeneca Korea announced that Atacand (candesarten cilexetil), an angiotensin receptor blocker (ARB) for the treatment of hypertension, has been approved by the Korea Food and Drug Administration (KFDA) for the tre...
